Dr. Sofia Lakhdar, MD

Dr. Lakhdar practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Lakhdar's NPI, 1225599574, was assigned on March 28, 2019. Dr. Lakhdar holds Louisiana license 331234.

Dr. Lakhdar's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Lakhdar's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Lakhdar is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Lakhdar to 2 more hospitals and 3 medical groups, each named with a free account. Dr. Lakhdar's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lakhdar practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lakhdar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Lakhdar's licenses on file in 2 states: Louisiana and New York.

CMS data shows 26 Medicare services from Dr. Lakhdar across 2 procedure codes in 2024, for 35 Medicare patients. Medicare paid $1,570 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Lakhdar in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lakhdar's median patient age at 68, with 45% women.

In 2024, Dr. Lakhdar wrote 279 Medicare Part D claims for 69 patients. 73% of them were for generic drugs. CMS names the drug for 168 of them, across 10 drugs with 11 or more claims each, at $37,738 in total drug cost. In 2019, CMS named 12 claims across 1 drug.

Dr. Lakhdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lakhdar as offering telehealth.

Dmand AI links 20 papers to Dr. Lakhdar, published from 2020 to 2023. 2022 was the busiest year, with 10. The most frequent topics are Heart Failure, Cardiomyopathies and COVID-19. Dr. Lakhdar has published most often in Cureus. Dr. Lakhdar's most frequent co-authors are Nso A. Nso, MD, MPH, Vincent Rizzo, MD and Theo Trandafirescu.

CMS Open Payments shows 96 general payments to Dr. Lakhdar from 17 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $483.